Zhongyue Xing

Zhongyue Xing

Auto-generated profile, based on publicly available information

Zhongyue Xing

School of Public Health and Preventive Medicine, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne , 161 Barry St, Carlton VIC 3010

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2025 in Oxford Open Digital Health
Verified
Journal Article
Open access
EBEvangelia Baka
Evangelia Baka
YTYi-Roe Tan
Yi-Roe Tan
BWBrian Li Han Wong
Brian Li Han Wong
ZXZhongyue Xing
Zhongyue Xing
PYPeiling Yap
Peiling Yap
Digital mental health (DMH) interventions leveraging digital technologies, such as mobile applications, web-based platforms, artificial intelligence and wearable devices, have emerged as a promising avenue for addressing the mental health needs of young people. This scoping review examines the landscape of primary and secondary preventive DMH interventions for young people aged 10–24 years. Six electronic databases were searched, leading to a final incorporation of 81 studies published between 2010 and 2022. Each of these studies corresponds to a unique DMH intervention. Our findings reveal that research activity in the area of promotive and preventive DMH interventions started gaining ground from 2019 onwards, with the majority of studies conducted in Australia and the USA. 70% of the total studies targeted the prevention of mental health conditions. Randomized controlled trials were the predominant study methodology, while mental well-being, depressive disorders, anxiety disorders, life skills and disorders specifically associated with stress were the most targeted mental health or well-being conditions. Finally, mobile applications and web interfaces were the most studied form of DMH interventions. Most of these applications have integrated advanced AI/ML algorithms to serve the purpose of personalization and real-time monitoring. However, there is a marked need for more emphasis on preventive and, especially, promotive mental health measures, as well as the active inclusion of low- and middle-income countries in future research.

16 December 2022 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
CFCalvin M. Fletcher
Calvin M. Fletcher
JHJake V. Hinton
Jake V. Hinton
ZXZhongyue Xing
Zhongyue Xing
LPLuke A. Perry
Luke A. Perry
AKAlexandra Karamesinis
Alexandra Karamesinis
RBRinaldo Bellomo
Rinaldo Bellomo

12 December 2023 in Perfusion
Verified
Journal Article
Closed access
CFCalvin M Fletcher
Calvin M Fletcher
JHJake V Hinton
Jake V Hinton
ZXZhongyue Xing
Zhongyue Xing
LPLuke A Perry
Luke A Perry
AKAlexandra Karamesinis
Alexandra Karamesinis
RBRinaldo Bellomo
Rinaldo Bellomo
Introduction: Fresh frozen plasma (FFP) transfusion in the intensive care unit (ICU) is commonly used to treat coagulopathy and bleeding in cardiac surgery, despite suggestion that it may increase the risk of morbidity and mortality through mechanisms such as fluid overload and infection. Methods: We retrospectively studied consecutive adults undergoing cardiac surgery from the Medical Information Mart for Intensive Care III and IV databases. We applied propensity score matching to investigate the independent association of within-ICU FFP transfusion with mortality and other key clinical outcomes. Results: Of our 12,043 adults who met inclusion criteria, 1585 (13.2%) received perioperative FFP with a median of 2.48 units per recipient (interquartile range [IQR]: 2.04, 4.33) at a median time of 1.83 h (IQR: 0.75, 3.75) after ICU admission. After propensity matching of 952 FFP recipients to 952 controls, we found no significant association between FFP use and hospital mortality (odds ratio (OR): 1.58; 99% confidence interval (CI): 0.57, 3.71), suspected infection (OR: 0.72; 99% CI: 0.49, 1.08), or acute kidney injury (OR: 1.23; 99% CI: 0.91, 1.67). However, FFP was associated with increased days in hospital (adjusted mean difference (AMD): 1.28; 99% CI: 0.27, 2.41; p = .0050), days in intensive care (AMD: 1.28; 99% CI: 0.27, 2.28; p = .0011), and chest tube output in millilitres up to 8 h after transfusion (AMD: 92.98; 99% CI: 52.22, 133.74; p < .0001). Conclusions: After propensity matching, FFP transfusion was not associated with increased hospital mortality, but was associated with increased length of stay and no decrease in bleeding in the early post-transfusion period.